252 related articles for article (PubMed ID: 35519160)
21. Biological disease-modifying antirheumatic drugs in juvenile idiopathic arthritis of polyarticular course, enthesitis-related arthritis, and psoriatic arthritis: a consensus statement.
Ho ACH; Wong SN; Leung LCK; Chan WKY; Chong PCY; Tse NKC; Yeung RHM; Kong SY; Lee KP
Hong Kong Med J; 2020 Feb; 26(1):56-65. PubMed ID: 32077861
[TBL] [Abstract][Full Text] [Related]
22. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
[TBL] [Abstract][Full Text] [Related]
23. Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.
Ong MS; Ringold S; Kimura Y; Schanberg LE; Tomlinson GA; Natter MD;
Arthritis Rheumatol; 2021 Oct; 73(10):1910-1920. PubMed ID: 34105303
[TBL] [Abstract][Full Text] [Related]
24. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
25. Juvenile Idiopathic Arthritis.
Barut K; Adrovic A; Şahin S; Kasapçopur Ö
Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
[TBL] [Abstract][Full Text] [Related]
26. Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
Felis-Giemza A; Chmurzyńska K; Kołodziejczyk B; Gazda A
Rheumatol Int; 2023 Jul; 43(7):1307-1311. PubMed ID: 36859560
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of overweight among Moroccan children and adolescents with juvenile idiopathic arthritis.
Amine B; Ibn Yacoub Y; Rostom S; Hajjaj-Hassouni N
Joint Bone Spine; 2011 Dec; 78(6):584-6. PubMed ID: 21441059
[TBL] [Abstract][Full Text] [Related]
28. Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra.
Kearsley-Fleet L; Beresford MW; Davies R; De Cock D; Baildam E; Foster HE; Southwood TR; Thomson W; Hyrich KL
Rheumatology (Oxford); 2019 Jan; 58(1):94-102. PubMed ID: 30137641
[TBL] [Abstract][Full Text] [Related]
29. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
Brunner HI; Ruperto N; Zuber Z; Cuttica R; Keltsev V; Xavier RM; Burgos-Vargas R; Penades IC; Silverman ED; Espada G; Zavaler MF; Kimura Y; Duarte C; Job-Deslandre C; Joos R; Douglass W; Wimalasundera S; Bharucha KN; Wells C; Lovell DJ; Martini A; de Benedetti F;
Arthritis Rheumatol; 2021 Mar; 73(3):530-541. PubMed ID: 32951358
[TBL] [Abstract][Full Text] [Related]
31. Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.
Marino A; Stagi S; Simonini G; Carli N; Caparello MC; Giani T; Pagnini I; De Masi S; Cimaz R
Clin Exp Rheumatol; 2018; 36(5):929-933. PubMed ID: 30148444
[TBL] [Abstract][Full Text] [Related]
32. Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group.
Demirkan FG; Ulu K; Öztürk K; Karadağ ŞG; Özdel S; Sönmez HE; Çakmak F; Demir F; Sözeri B; Aktay Ayaz N
Expert Opin Biol Ther; 2022 Feb; 22(2):197-202. PubMed ID: 34730483
[TBL] [Abstract][Full Text] [Related]
33. Tocilizumab for juvenile idiopathic arthritis: a single-center case series.
Yazılıtaş F; Özdel S; Şimşek D; Aydoğ Ö; Çakıcı EK; Can GG; Güngör T; Bülbül M
Sao Paulo Med J; 2019; 137(6):517-522. PubMed ID: 32159638
[TBL] [Abstract][Full Text] [Related]
34. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Barut K; Adrovic A; Sahin S; Tarcin G; Tahaoglu G; Koker O; Yildiz M; Kasapcopur O
Int J Rheum Dis; 2019 Sep; 22(9):1661-1669. PubMed ID: 31273940
[TBL] [Abstract][Full Text] [Related]
35. Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
Alexeeva EI; Namazova-Baranova LS; Bzarova TM; Valieva SI; Denisova RV; Sleptsova TV; Isaeva KB; Chomahidze AM; Taibulatov NI; Fetisova AN; Karaseva AV; Baranov AA
Pediatr Rheumatol Online J; 2017 Jun; 15(1):51. PubMed ID: 28615036
[TBL] [Abstract][Full Text] [Related]
36. Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab Group.
Al-Mayouf SM; Hashad S; Khawaja K; Alrasheedi A; Abdwani R; Abushhaiwia A; AlSuwaiti M; Alzyoud R; Al Abrawi S; Asiri A; Alshaikh M; Sharif E; Muzaffer M; Alsewairi W; Zlenti M; Kawaja E; Almutairi M; Majeed M; Lotfy H; AlMarri M; Almutairi N;
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):586-592. PubMed ID: 32886859
[TBL] [Abstract][Full Text] [Related]
37. Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.
Khawaja K; Kalas R; Almasri N
Pediatr Rheumatol Online J; 2023 Feb; 21(1):14. PubMed ID: 36750870
[TBL] [Abstract][Full Text] [Related]
38. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
Niewerth M; Minden K; Klotsche J; Horneff G
Z Rheumatol; 2014 Aug; 73(6):532-40. PubMed ID: 25096586
[TBL] [Abstract][Full Text] [Related]
39. Treatment of juvenile idiopathic arthritis: a revolution in care.
Stoll ML; Cron RQ
Pediatr Rheumatol Online J; 2014; 12():13. PubMed ID: 24782683
[TBL] [Abstract][Full Text] [Related]
40. Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage.
Al-Mayouf SM; Alrasheedi A; Almsellati I; Hashad S; Khawaja K; Abdwani R; AlHashim S; Muzaffer M; Lotfy H; Almutairi N
Int J Rheum Dis; 2021 Aug; 24(8):1080-1085. PubMed ID: 34184820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
